These findings were supported by the high expression of DEF6 in two serous, two clear cell and one endometrioid carcinoma cell lines, suggestive of the frequent expression of DEF6 in ovarian carcinoma tissues and cells. The gene discussed is DEF6; the disease is endometrioid adenocarcinoma.